In individuals fulfilling the diagnostic criteria for CHARGE syndrome, CHD7 sequencing and targeted analyses directed to identify structural rearrangements involving the gene are expected to confirm the diagnosis in all cases. This evidence concerns the gene CHD7 and CHARGE syndrome.